Polymorphisms: GSTO2*N142D (A424G; rs156697) and other GSTs (GSTP1, GSTM1, GSTT1, GSTZ1)Main findings:- positive association between GSTO2*N142D variant and bladder cancer risk independently of arsenic exposure. Here, HPGDS is linked to urinary bladder cancer.